Clinical Trial Update: Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of oral roflumilast for moderate to severe atopic dermatitis in patients aged 12 years and older is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Nora Mohamed Abdelrazik | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING